Gimme Care vs Push Health
Gimme Care costs $820 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Gimme Care
Best for: semaglutide at $130/month, 39% below the typical price
Visit Gimme Care →
If you are choosing between Gimme Care and Push Health, the first difference is cost: Gimme Care is $820 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Gimme Care leads our six-part score, 8.7 to 5.6.
Gimme Care vs Push Health price
Gimme Care is the cheaper way in: $130 a month against $950 a month at Push Health. That is $820 less each month (86% lower), or about $9,840 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Gimme Care ($130 a month vs $950 a month).
Medications and formats
Both sell semaglutide; only Gimme Care lists tirzepatide.
On format, Gimme Care prices compounded injections, while Push Health prices brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Push Health is the only one of the two with a brand-name price.
Where each one treats patients
Gimme Care lists 51 states, and Push Health does not publish where it ships.
Pricing
Gimme Care
Push Health
Ozempic / brand
What each price covers
Gimme Care's price also covers the clinician visit, the medication itself and shipping, which Push Health does not claim.
Gimme Care is silent on lab work and coaching.
Push Health does not say what its price includes.
That matters most for the drug: unless Push Health confirms otherwise, budget for medication on top of its listed price.
Gimme Care
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Push Health
Inclusions not disclosed.
Where each one scores higher
Overall, Gimme Care scores 8.7 and Push Health 5.6 out of 10.
Gimme Care is stronger on value (8.1 vs 5.3), effectiveness (10.0 vs 9.0), user experience (8.0 vs 3.0), trust & safety (8.5 vs 4.0), accessibility (10.0 vs 5.0) and support (7.0 vs 5.0).
Gimme Care
8.7/10
Push Health
5.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Gimme Care nor Push Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | Gimme Care | Push Health |
|---|---|---|
| Starting Price | ✓$130/mo | $950/mo |
| Features | 5 features | 5 features |
| States Available | 51 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Gimme Care
Gimme Care sells compounded semaglutide at $130-$160/mo and compounded tirzepatide at $163-$199/mo, microdose options included. It is LegitScript verified, available in all 50 states plus DC, with no membership fees.
Read our full Gimme Care review →About Push Health
A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.
Read our full Push Health review →Pros & Cons
Gimme Care
What we like
- Semaglutide costs $130 a month, 29% below the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $163 a month, 35% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Gimme Care
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Push Health
What we like
- Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
- We found no FDA warning letters issued to Push Health
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Gimme Care wins this one, 8.7 to 5.6, above all for semaglutide at $130/month, 39% below the typical price. It also costs $820 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.
Choose Gimme Care if…
You want semaglutide at $130/month, 39% below the typical price and an opening price near $130 a month.
Choose Push Health if…
You want semaglutide from $950/month and an opening price near $950 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →Gimme Care vs Push Health: FAQ
Close alternatives to Gimme Care and Push Health
- Gimme Care vs Bioverse
- Gimme Care vs Alternate Health Club
- Gimme Care vs DoctorAdam
- Gimme Care vs Longevixx
- Push Health vs JumpstartMD
- Push Health vs Marek Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.